Janus Kinase 3, antagonists & inhibitors

All categories
DBCAT001910Pharmacologic class

A DrugBank category of 1 drug. 1 of them is approved.

Part of
Janus Kinases, antagonists & inhibitors
Drugs

What you can answer from here — as of July 17, 2023

1DrugEach linked to its full drug card
Listed above
6Drug targetsEvery drug–target pair in the class, with bond type
Sign in
10Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
1Route of administrationHow the drugs in this class are given
Sign in

Which targets do Janus Kinase 3, antagonists & inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In